Drug screening identified bosutinib, a Src/c-Abl inhibitor that promotes autophagy and rescues ALS MN degeneration by inhibiting misfolded SOD1 aggregation and suppressing cell death in familial and sporadic ALS cases. Here, ABL1 is linked to amyotrophic lateral sclerosis.